对ROS敏感的纳米粒子输送的obeticholic 酸可以缓解原发性硬化胆管炎
Qigu Yao1, Beiduo Wang2, Jiong Yu3
1State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Medical Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou City 310003, China.
概括
一种新的疗法将肥酸 (OCA) 封装在生物模拟平台中,对原发性硬化性胆道炎 (PSC) 显示出希望. 这种新疗法在临床前模型中减少了肝损伤和炎症,为PSC患者提供了更安全的方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
背景情况:
- 原发性硬化性脑膜炎 (PSC) 是一种严重的胆固醇性肝病,缺乏有效的FDA批准的治疗方法.
- 固醇酸 (OCA) 显示PSC的潜力,但受到肝毒性限制.
研究的目的:
- 开发和评估PSC的新型治疗构造.
- 评估通过反应性氧物种 (ROS) 响应的仿生平台传递的OCA的疗效和安全性.
主要方法:
- 开发了一种新的结构:OCA被封装在一种ROS响应的聚合物中,并被人类胎盘衍生的介质干细胞 (hP-MSC) 膜 (MPPFTU@OCA) 覆盖.
- 使用PSC患者衍生器官的评估细胞吸收和细胞毒性.
- 在DDC诱导的PSC小鼠模型中评估治疗疗效,测量胆固醇,炎症,ROS水平和亡.
- 在H2O2刺激的PSC有机体中量化线粒体功能 (ATP,ROS,膜潜力).
主要成果:
- 在有机体模型中,MPPFTU@OCA证明了细胞吸收的改善和细胞毒性降低.
- 在体内,MPPFTU@OCA治疗通过PSC小鼠模型的FXR-SHP途径改善胆固醇.
- 治疗减少了巨细胞透,细胞内ROS积累和线粒体亡.
- MPPFTU@OCA有效抑制了线粒体ROS,缓解了PSC有机体的亡.
结论:
- 新的ROS响应,仿生平台 (MPPFTU@OCA) 为PSC提供了一个有前途的治疗策略.
- 这种方法可以减轻OCA的肝毒性,同时提高其疗效.
- 这些发现突出了将先进生物材料与肝脏疾病的向药物输送相结合的潜力.
相关概念视频
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...